Identifying non-alcoholic fatty liver disease fibrosis risk in type 2 diabetes patients: implementing the right care, in the right place, at the right time (NAFLD-RRR study)

Not Applicable

• Conditions: onalcoholic fatty liver disease; Type 2 Diabetes; Nonalcoholic fatty liver disease; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12621000330842
• Lead Sponsor: PA Hospital Foundation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-03-23
• Last Update Posted: 24 May 2021

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

•Referred to a Diabetes Clinic for management of type 2 diabetes
•Aged >/=18 years
•Understand the consent procedures and give their full consent .
•Consent to access their Queensland Health, primary care and Medicare Benefits
Schedule (MBS)/Pharmaceutical Benefits Schedule (PBS) data.

Exclusion Criteria

Are pregnant.
Have advanced cardiac disease or another terminal illness.
NESB and interpreter not available

Study & Design

• Study Type: Interventional
• Study Design: Not specified